Kindex Therapeutics LLC - WA King, Seattle 98104

Kindex Therapeutics LLC entered the industry of Commercial Biotechnical Research in 2009 and has grown to employ 1 to 4 people, generating an annual revenue of $100.000 to $499.999. The NAICS classifies this business under the code 4461910, which describes it as a Commercial Biotechnical Research. For further clarification, the SIC classifies this business under the code 8731 and described it as a Commercial Biotechnical Research. The business provides service to the B2B market.

To acquire more information, please contact Jeffrey Bland by calling (206) 447-1455 during business hours. You can also write to the business’ Branch at 800 5th Avenue # 4100, Seattle, Washington WA 98104. You can also visit the company’s website at kindextherapeutics.com. View this business’ social media profiles on Twitter or on Facebbok .

Company: Kindex Therapeutics LLC
Representative: Jeffrey Bland
Place of Business: 800 5th Avenue # 4100, Seattle, WA 98104
Contact Number: (206) 447-1455
Website: kindextherapeutics.com
Type of Service: Commercial Biotechnical Research
SIC Number: 8731
NAICS Number: 4461910
Locality: Branch
Market Type: B2B (Business to Business)
Began: 2009
Income/Year: $100.000 to $499.999
Laborers: 1 to 4
Share This Company:

Kindex Therapeutics LLC is a company operating from King, Washington providing professional Commercial Biotechnical Research and relevant B2B variables. It was founded in 2009 and registered with the SIC code 8731 as Commercial Biotechnical Research, and with the NAICS code 4461910 as Commercial Biotechnical Research.

With a current employee count of 1 to 4, Kindex Therapeutics LLC has gone to report making $100.000 to $499.999 per annum on its journey towards growth. This company invites you to contact its representative Jeffrey Bland at (206) 447-1455 for related queries, or to locate its Branch using the coordinates 47.605171,-122.330444.

The Branch can also be found at the street address 800 5th Avenue # 4100 in Seattle, Washington 98104 and can be engaged online through the company website at kindextherapeutics.com, the company Twitter , and Facebook page .